From: Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis
Aortic stenosis (N = 104) | AS + CA (N = 9) | P Value | ||
---|---|---|---|---|
Clinical | Age (years) | 70 ± 14 | 88 ± 6 | < 0.001 |
Male Gender | 58 (56%) | 8 (89%) | 0.057 | |
Hypertension | 76 (73.1%) | 7 (77.8%) | 0.866 | |
Diabetes | 36 (34.6%) | 3 (33.3%) | 0.890 | |
Creatinine (mg/dl) | 1.26 ± 0.94 | 1.54 ± 0.45 | 0.380 | |
Prior Revascularization (PCI or CABG) | 33 (31.7%) | 3 (33.3%) | 0.968 | |
NYHA Class ≥ III at baseline | 57 (55%) | 7 (78%) | 0.182 | |
Atrial Fibrillation/Flutter | 21 (20.2%) | 6 (67%) | 0.006 | |
STS Predicted Risk of Mortality (STS PROM) (%) | 3.8 ± 3.7 | 6.9 ± 4.2 | 0.024 | |
Any AVR (Surgical or Transcatheter) | 55 (53%) | 4 (44.4%) | 0.627 | |
Echocardiographic | Interventricular Septal Thickness (cm) | 1.3 ± 0.3 | 1.8 ± 0.5 | < 0.001 |
Relative Wall Thickness (PWT/LVEDD) | 0.5 ± 0.3 | 0.7 ± 0.3 | 0.147 | |
Left Atrial Volume Index (ml/m2) | 40 ± 15 | 51 ± 13 | 0.037 | |
Septal s’ (cm/s) | 4.8 ± 1.7 | 2.9 ± 1.0 | 0.008 | |
Septal e’ (cm/s) | 4.9 ± 2.0 | 3.5 ± 1.2 | 0.084 | |
E/e’ ratio (Lateral) | 18 ± 11 | 19 ± 4 | 0.942 | |
E/e’ ratio (Septal) | 25 ± 18 | 33 ± 10 | 0.281 | |
LV Stroke Volume Index (ml/m2) | 37 ± 12 | 25 ± 7 | 0.003 | |
Indexed Aortic Valve Area (cm2/m2) | 0.5 ± 0.2 | 0.4 ± 0.2 | 0.047 | |
Severe AS (indexed AVA ≤ 0.6 cm2/m2) | 80 (77%) | 8 (89%) | 0.43 | |
AV Mean Gradient (mmHg) | 31 ± 15 | 30 ± 14 | 0.924 | |
Low-Flow, Low-Gradient Physiologya (%) | 47 (45%) | 7 (78%) | 0.060 | |
Pulmonary Artery Systolic Pressure (mmHg) | 41 ± 13 | 45 ± 17 | 0.435 | |
CMR | LV End-Diastolic Volume Index (ml/m2) | 92 ± 33 | 82 ± 19 | 0.113 |
LV End-Systolic Volume Index (ml/m2) | 48 ± 33 | 49 ± 22 | 0.131 | |
LV Stroke Volume Index (ml/m2) | 44 ± 13 | 33 ± 10 | 0.024 | |
LV Ejection Fraction (%) | 52 ± 18 | 43 ± 17 | 0.176 | |
LV Mass Index (g/m2) | 73 ± 21 | 105 ± 21 | < 0.0001 | |
LV Mass/Volume Ratio (LV Mass/LVEDV) | 0.8 ± 0.2 | 1.3 ± 0.3 | 0.02 | |
Native T1 mapping (msec)b | 1035 ± 60 | 1125 ± 49 | 0.002 | |
Extracellular Volume Fraction (ECV) (%)c | 27.9 ± 4.1 | 41.2 ± 16.7 | < 0.001 |